Form 8-K - Current report
08 Marzo 2024 - 3:38PM
Edgar (US Regulatory)
0000805928false00008059282024-03-072024-03-07
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 8-K
Current Report
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): March 7, 2024
AXOGEN, INC.
(Exact Name of Registrant as Specified in Charter)
Minnesota
(State or Other Jurisdiction of
Incorporation or Organization)
001-36046
(Commission File Number)
41-1301878
(I.R.S. Employer Identification No.)
13631 Progress Boulevard, Suite 400 Alachua, Florida
(Address of principal executive offices)
(386) 462-6800
(Registrant's telephone number, including area code)
N/A
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| | | | | |
☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e- 4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| | | | | | | | |
Title of each class | Trading Symbol(s) | Name of exchange on which registered |
Common Stock, $0.01 par value | AXGN | The Nasdaq Stock Market |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Directors.
Angelo Scopelianos notified Axogen, Inc. (the “Company”) of his intention to resign as the Company’s Chief Research and Development Officer no later than March 31, 2024 (the “Separation Date”). Mr. Scopelianos will provide transition services as a consultant for a period commencing on the Separation Date and ending on December 31, 2024 (the “Consulting Period). The Consulting Period may be extended further upon mutual agreement of the Company and Mr. Scopelianos and may be terminated by the Company for cause. In connection with his provision of consulting services for up to 10 hours of work per week, Mr. Scopelianos will be eligible to receive a monthly fee of $9,079.16 per month. If Mr. Scopelianos provides consulting services through October 1, 2024, he will also be entitled to a one-time additional payment of $75,000.
Pursuant to the terms of the Transition and Separation Agreement, dated March 7, 2024, between Axogen Corporation, a Delaware corporation and wholly owned subsidiary of the Company and Mr. Scopelianos (the “Transition Agreement”), Mr. Scopelianos will be entitled to his 2023 bonus amount of $228,385.26, which will be paid out on March 15, 2024. With regards to outstanding unvested equity awards held by Mr. Scopelianos, (i) unvested stock options will continue to vest through the end of the Consulting Period, (ii) unvested restricted stock units will cease vesting as of the Separation Date, and (iii) any vested performance stock units (“PSUs”) will settle based on the Company’s actual achievement of the applicable goals as determined by the Company’s Board of Directors. and any unvested PSUs will cease vesting as of the Separation Date.
As part of the transition, Mr. Scopelianos is subject to ongoing non-competition provision and other restrictive covenant obligations through the Consulting Period.
Mr. Scopelianos’ product development responsibilities will be assumed by Ms. Stacy Arnold, Vice President of Product Development and Clinical Research, who is not an executive officer but is a member of the executive team and reports directly to the Company’s CEO, Karen Zaderej.
The foregoing description of the Transition Agreement is a summary and is qualified in its entirety by the full text of the Transition Agreement, which is attached hereto as Exhibit 10.1 and incorporated by reference herein.
Item 9.01. Financial Statements and Exhibits
| | | | | |
(d) Exhibits | See the Exhibit index below, which is incorporated herein by reference. |
| |
Exhibit No. | Description |
10.1 | |
104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |
SIGNATURES
Pursuant to the requirements of the Exchange Act, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | | | | | | | |
| AXOGEN, INC. |
| |
Dated: March 7, 2024 | By: | Marc Began |
| | Marc Began |
| | Executive Vice President, General Counsel and Chief Compliance Officer |
DocuSign Envelope ID: 6C7F4528-363F-47F1-852D-EB5D1C15BF34
DocuSign Envelope ID: 6C7F4528-363F-47F1-852D-EB5D1C15BF34
DocuSign Envelope ID: 6C7F4528-363F-47F1-852D-EB5D1C15BF34
DocuSign Envelope ID: 6C7F4528-363F-47F1-852D-EB5D1C15BF34
DocuSign Envelope ID: 6C7F4528-363F-47F1-852D-EB5D1C15BF34
DocuSign Envelope ID: 6C7F4528-363F-47F1-852D-EB5D1C15BF34
DocuSign Envelope ID: 6C7F4528-363F-47F1-852D-EB5D1C15BF34
DocuSign Envelope ID: 6C7F4528-363F-47F1-852D-EB5D1C15BF34
DocuSign Envelope ID: 6C7F4528-363F-47F1-852D-EB5D1C15BF34
DocuSign Envelope ID: 6C7F4528-363F-47F1-852D-EB5D1C15BF34
DocuSign Envelope ID: 6C7F4528-363F-47F1-852D-EB5D1C15BF34
DocuSign Envelope ID: 6C7F4528-363F-47F1-852D-EB5D1C15BF34 3/7/2024 Executive VP & General Counsel Marc Began 3/7/2024
DocuSign Envelope ID: 6C7F4528-363F-47F1-852D-EB5D1C15BF34
DocuSign Envelope ID: 6C7F4528-363F-47F1-852D-EB5D1C15BF34
DocuSign Envelope ID: 6C7F4528-363F-47F1-852D-EB5D1C15BF34
DocuSign Envelope ID: 6C7F4528-363F-47F1-852D-EB5D1C15BF34
DocuSign Envelope ID: 6C7F4528-363F-47F1-852D-EB5D1C15BF34
DocuSign Envelope ID: 6C7F4528-363F-47F1-852D-EB5D1C15BF34
DocuSign Envelope ID: 6C7F4528-363F-47F1-852D-EB5D1C15BF34
DocuSign Envelope ID: 6C7F4528-363F-47F1-852D-EB5D1C15BF34
DocuSign Envelope ID: 6C7F4528-363F-47F1-852D-EB5D1C15BF34
DocuSign Envelope ID: 6C7F4528-363F-47F1-852D-EB5D1C15BF34
DocuSign Envelope ID: 6C7F4528-363F-47F1-852D-EB5D1C15BF34
DocuSign Envelope ID: 6C7F4528-363F-47F1-852D-EB5D1C15BF34
DocuSign Envelope ID: 6C7F4528-363F-47F1-852D-EB5D1C15BF34
DocuSign Envelope ID: 6C7F4528-363F-47F1-852D-EB5D1C15BF34
DocuSign Envelope ID: 6C7F4528-363F-47F1-852D-EB5D1C15BF34
DocuSign Envelope ID: 6C7F4528-363F-47F1-852D-EB5D1C15BF34
DocuSign Envelope ID: 6C7F4528-363F-47F1-852D-EB5D1C15BF34
DocuSign Envelope ID: 6C7F4528-363F-47F1-852D-EB5D1C15BF34
DocuSign Envelope ID: 6C7F4528-363F-47F1-852D-EB5D1C15BF34
DocuSign Envelope ID: 6C7F4528-363F-47F1-852D-EB5D1C15BF34
DocuSign Envelope ID: 6C7F4528-363F-47F1-852D-EB5D1C15BF34
DocuSign Envelope ID: 6C7F4528-363F-47F1-852D-EB5D1C15BF34
DocuSign Envelope ID: 6C7F4528-363F-47F1-852D-EB5D1C15BF34
DocuSign Envelope ID: 6C7F4528-363F-47F1-852D-EB5D1C15BF34
DocuSign Envelope ID: 6C7F4528-363F-47F1-852D-EB5D1C15BF34
DocuSign Envelope ID: 6C7F4528-363F-47F1-852D-EB5D1C15BF34
DocuSign Envelope ID: 6C7F4528-363F-47F1-852D-EB5D1C15BF34
DocuSign Envelope ID: 6C7F4528-363F-47F1-852D-EB5D1C15BF34
DocuSign Envelope ID: 6C7F4528-363F-47F1-852D-EB5D1C15BF34
DocuSign Envelope ID: 6C7F4528-363F-47F1-852D-EB5D1C15BF34
DocuSign Envelope ID: 6C7F4528-363F-47F1-852D-EB5D1C15BF34
DocuSign Envelope ID: 6C7F4528-363F-47F1-852D-EB5D1C15BF34
DocuSign Envelope ID: 6C7F4528-363F-47F1-852D-EB5D1C15BF34
DocuSign Envelope ID: 6C7F4528-363F-47F1-852D-EB5D1C15BF34
DocuSign Envelope ID: 6C7F4528-363F-47F1-852D-EB5D1C15BF34
DocuSign Envelope ID: 6C7F4528-363F-47F1-852D-EB5D1C15BF34
DocuSign Envelope ID: 6C7F4528-363F-47F1-852D-EB5D1C15BF34
v3.24.0.1
Cover
|
Mar. 07, 2024 |
Cover [Abstract] |
|
Document Type |
8-K
|
Document Period End Date |
Mar. 07, 2024
|
Entity Registrant Name |
AXOGEN, INC.
|
Entity Incorporation, State or Country Code |
MN
|
Entity File Number |
001-36046
|
Entity Tax Identification Number |
41-1301878
|
Entity Address, Address Line One |
13631 Progress Boulevard, Suite 400
|
Entity Address, City or Town |
Alachua
|
Entity Address, State or Province |
FL
|
Entity Address, Postal Zip Code |
32615
|
City Area Code |
386
|
Local Phone Number |
462-6800
|
Written Communications |
false
|
Soliciting Material |
false
|
Pre-commencement Tender Offer |
false
|
Pre-commencement Issuer Tender Offer |
false
|
Title of 12(b) Security |
Common Stock, $0.01 par value
|
Trading Symbol |
AXGN
|
Security Exchange Name |
NASDAQ
|
Entity Emerging Growth Company |
false
|
Entity Central Index Key |
0000805928
|
Amendment Flag |
false
|
X |
- DefinitionBoolean flag that is true when the XBRL content amends previously-filed or accepted submission.
+ References
+ Details
Name: |
dei_AmendmentFlag |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionFor the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.
+ References
+ Details
Name: |
dei_DocumentPeriodEndDate |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:dateItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.
+ References
+ Details
Name: |
dei_DocumentType |
Namespace Prefix: |
dei_ |
Data Type: |
dei:submissionTypeItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAddress Line 1 such as Attn, Building Name, Street Name
+ References
+ Details
Name: |
dei_EntityAddressAddressLine1 |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- Definition
+ References
+ Details
Name: |
dei_EntityAddressCityOrTown |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionCode for the postal or zip code
+ References
+ Details
Name: |
dei_EntityAddressPostalZipCode |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionName of the state or province.
+ References
+ Details
Name: |
dei_EntityAddressStateOrProvince |
Namespace Prefix: |
dei_ |
Data Type: |
dei:stateOrProvinceItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionA unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityCentralIndexKey |
Namespace Prefix: |
dei_ |
Data Type: |
dei:centralIndexKeyItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionIndicate if registrant meets the emerging growth company criteria.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityEmergingGrowthCompany |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionCommission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.
+ References
+ Details
Name: |
dei_EntityFileNumber |
Namespace Prefix: |
dei_ |
Data Type: |
dei:fileNumberItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTwo-character EDGAR code representing the state or country of incorporation.
+ References
+ Details
Name: |
dei_EntityIncorporationStateCountryCode |
Namespace Prefix: |
dei_ |
Data Type: |
dei:edgarStateCountryItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityRegistrantName |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityTaxIdentificationNumber |
Namespace Prefix: |
dei_ |
Data Type: |
dei:employerIdItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionLocal phone number for entity.
+ References
+ Details
Name: |
dei_LocalPhoneNumber |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 13e -Subsection 4c
+ Details
Name: |
dei_PreCommencementIssuerTenderOffer |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 14d -Subsection 2b
+ Details
Name: |
dei_PreCommencementTenderOffer |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTitle of a 12(b) registered security.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b
+ Details
Name: |
dei_Security12bTitle |
Namespace Prefix: |
dei_ |
Data Type: |
dei:securityTitleItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionName of the Exchange on which a security is registered.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection d1-1
+ Details
Name: |
dei_SecurityExchangeName |
Namespace Prefix: |
dei_ |
Data Type: |
dei:edgarExchangeCodeItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Section 14a -Number 240 -Subsection 12
+ Details
Name: |
dei_SolicitingMaterial |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTrading symbol of an instrument as listed on an exchange.
+ References
+ Details
Name: |
dei_TradingSymbol |
Namespace Prefix: |
dei_ |
Data Type: |
dei:tradingSymbolItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Securities Act -Number 230 -Section 425
+ Details
Name: |
dei_WrittenCommunications |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
Axogen (NASDAQ:AXGN)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Axogen (NASDAQ:AXGN)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024